146 related articles for article (PubMed ID: 14752080)
21. [Chronic lymphocytic and prolymphocytic leukemia].
Gerrits CJ; Michiels JJ
Ned Tijdschr Geneeskd; 1995 Apr; 139(16):826-30. PubMed ID: 7731474
[No Abstract] [Full Text] [Related]
22. Effectiveness of fludarabine in end-stage prolymphocytic leukemia.
Doorduijn JK; Michiels JJ
Leukemia; 1994 Aug; 8(8):1439. PubMed ID: 8057685
[No Abstract] [Full Text] [Related]
23. A case of erythrodermic-CTCL.
Shimoda T; Aoki M; Takezaki S; Futagami A; Inokuchi K; Sugisaki Y; Kawana S
Leuk Lymphoma; 2006 Aug; 47(8):1708-10. PubMed ID: 16966295
[No Abstract] [Full Text] [Related]
24. Allogeneic stem cell transplantation after reduced-intensity conditioning in a patient with T-cell prolymphocytic leukemia: graft-versus-tumor effect and long-term remission.
de Lavallade H; Faucher C; Fürst S; El-Cheikh J; Vey N; Coso D; Bouabdallah R; Stoppa AM; Gastaut JA; Blaise D; Mohty M
Bone Marrow Transplant; 2006 Apr; 37(7):709-10. PubMed ID: 16474410
[No Abstract] [Full Text] [Related]
25. Complete remission in T-cell prolymphocytic leukemia with 2-chlorodeoxyadenosine.
Palomera L; Domingo JM; Agulló JA; Soledad Romero M
J Clin Oncol; 1995 May; 13(5):1284-5. PubMed ID: 7738636
[No Abstract] [Full Text] [Related]
26. Chlorambucil and prednisolone therapy in a patient with T-cell chronic lymphocytic leukaemia.
Islam A; Majer R; Cumber P; Poynton C
Clin Lab Haematol; 1996 Jun; 18(2):125-6. PubMed ID: 8866149
[No Abstract] [Full Text] [Related]
27. T-cell prolymphocytic leukemia: an aggressive T cell malignancy with frequent cutaneous tropism.
Magro CM; Morrison CD; Heerema N; Porcu P; Sroa N; Deng AC
J Am Acad Dermatol; 2006 Sep; 55(3):467-77. PubMed ID: 16908353
[TBL] [Abstract][Full Text] [Related]
28. Deoxycoformycin in the treatment of mature T-cell leukaemias.
Dearden C; Matutes E; Catovsky D
Br J Cancer; 1991 Nov; 64(5):903-6. PubMed ID: 1931613
[TBL] [Abstract][Full Text] [Related]
29. Phase I/II study of the mammalian target of rapamycin inhibitor everolimus (RAD001) in patients with relapsed or refractory hematologic malignancies.
Yee KW; Zeng Z; Konopleva M; Verstovsek S; Ravandi F; Ferrajoli A; Thomas D; Wierda W; Apostolidou E; Albitar M; O'Brien S; Andreeff M; Giles FJ
Clin Cancer Res; 2006 Sep; 12(17):5165-73. PubMed ID: 16951235
[TBL] [Abstract][Full Text] [Related]
30. Primary CD20+CD10+CD8+ T-cell lymphoma of the skin with IgH and TCR beta gene rearrangement.
Magro CM; Seilstad KH; Porcu P; Morrison CD
Am J Clin Pathol; 2006 Jul; 126(1):14-22. PubMed ID: 16753590
[TBL] [Abstract][Full Text] [Related]
31. Cutaneous involvement as the first manifestation in a case of T-cell prolymphocytic leukaemia.
Serra A; Estrach MT; Martí R; Villamor N; Rafel M; Montserrat E
Acta Derm Venereol; 1998 May; 78(3):198-200. PubMed ID: 9602226
[TBL] [Abstract][Full Text] [Related]
32. Translocation (8;14)(q24;q32) as the sole cytogenetic abnormality in B-cell prolymphocytic leukemia.
Kuriakose P; Perveen N; Maeda K; Wiktor A; Van Dyke DL
Cancer Genet Cytogenet; 2004 Apr; 150(2):156-8. PubMed ID: 15066324
[TBL] [Abstract][Full Text] [Related]
33. Involvement of central nervous system in prolymphocytoid transformation of chronic lymphocytic leukemia.
Kuwabara H; Kanamori H; Takasaki H; Takabayashi M; Yamaji S; Tomita N; Fujimaki K; Fujisawa S; Ishigatsubo Y
Leuk Lymphoma; 2003 Jul; 44(7):1235-7. PubMed ID: 12916878
[TBL] [Abstract][Full Text] [Related]
34. Skin and gingival lesions in a young woman with B-prolymphocytic leukemia (B-PLL).
Panteli K; Bai M; Basioukas K; Vartholomatos G; Zioga K; Bourantas KL
J Exp Clin Cancer Res; 2001 Sep; 20(3):447-9. PubMed ID: 11718228
[TBL] [Abstract][Full Text] [Related]
35. Cutaneous infiltration in T-cell prolymphocytic leukaemia.
Mallett RB; Matutes E; Catovsky D; Maclennan K; Mortimer PS; Holden CA
Br J Dermatol; 1995 Feb; 132(2):263-6. PubMed ID: 7888364
[TBL] [Abstract][Full Text] [Related]
36. Production of vascular endothelial growth factor in T-cell prolymphocytic leukemia.
Ogasawara T; Narita C; Kawauchi K
Leuk Res; 2007 Mar; 31(3):403-6. PubMed ID: 16620970
[TBL] [Abstract][Full Text] [Related]
37. Masquerade syndrome: T-cell prolymphocytic leukemia presenting as panuveitis.
Dhar-Munshi S; Alton P; Ayliffe WH
Am J Ophthalmol; 2001 Aug; 132(2):275-7. PubMed ID: 11476701
[TBL] [Abstract][Full Text] [Related]
38. T-cell prolymphocytic leukemia.
Dearden CE
Med Oncol; 2006; 23(1):17-22. PubMed ID: 16645226
[TBL] [Abstract][Full Text] [Related]
39. Flow cytometric immunophenotyping of adult T-cell leukemia/lymphoma using CD3 gating.
Yokote T; Akioka T; Oka S; Hara S; Kobayashi K; Nakajima H; Yamano T; Ikemoto T; Shimizu A; Tsuji M; Hanafusa T
Am J Clin Pathol; 2005 Aug; 124(2):199-204. PubMed ID: 16040289
[TBL] [Abstract][Full Text] [Related]
40. Development of aggressive T-cell leukemia at 1 month after the diagnosis of hypereosinophilic syndrome.
Yamamoto K; Doki N; Oshikawa G; Hanata N; Takizawa Y; Kubota N; Inoue M; Hagihara M; Kobayashi T; Kakihana K; Sakamaki H; Ohashi K
Leuk Lymphoma; 2014 Oct; 55(10):2402-4. PubMed ID: 24438196
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
